CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
Saved in:
| Title: | CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. |
|---|---|
| Authors: | Yamamoto Y; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan., Sugimoto A; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Maruo K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Tsujio G; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Sera T; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kushiyama S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Nishimura S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kuroda K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Togano S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Eguchi S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Tanaka R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Amano R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Yashiro M; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. |
| Source: | PloS one [PLoS One] 2022 Apr 04; Vol. 17 (4), pp. e0266027. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
